Patents expiring in 2034

US 8889867

Solid forms and process for preparing

Corcept Therapeutics Incorporated · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8889667

Therapeutic compounds and compositions

Agios Pharmaceuticals, Inc. · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8889658

Phosphonate compounds

The Regents of the University of California · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8889638

Stimulus-triggered prodrugs

The Regents of the University of California · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8889635

Dendrimer conjugates

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8889425

Means and methods for the determination of camp in vitro and in vivo

Bayerische Julius-Maximilians-Universität Würzburg · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8889627

Treatment of multiple sclerosis with combination of laquinimod and fingolimod

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8889625

Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia

Northwestern University · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

AU 2013258031

Parenteral esmolol formulation

AOP ORPHAN PHARMACEUTICALS AG [AT] · Granted Thu Nov 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

FR 3005577

TRAITEMENT DE L'INCONFORT BUCCAL

BIOCODEX [FR] · Granted Fri Nov 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Nov 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895591

Tricyclic compound and pharmaceutical use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895521

Methods and compositions for the treatment of uveitis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895539

Pregnancy hormone combination for treatment of autoimmune diseases

The Regents of the University of California · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895722

Splice-region antisense composition and method

Sarepta Therapeutics, Inc. · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895755

Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity

Theravance Biopharma R&D IP, LLC · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895717

Delivery of siRNA by neutral lipid compositions

The Board of Regents of the University of Texas System · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895018

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895242

Single molecule nucleic acid nanoparticles

The Regents of the University of California · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895072

Quantum dot barcode structures and uses thereof

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895078

Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts

BIONORICA ETHICS GMBH · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895055

Telodendrimer nanodiscs without apolipoprotein

The Regents of the University of California · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895537

Compositions and methods for treating cardiovascular diseases

Infirst Healthcare Limited · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895553

Oligomer-containing substituted aromatic triazine compounds

Nektar Therapeutics · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895578

Carboxamide, sulfonamide and amine compounds and methods for using the same

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895579

Heterotricyclic AMPA receptor antagonists for treatment of epilepsy, pain, and other neurological disorders and diseases

Northwestern University · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895588

Pyrazole compound

Takeda Pharmaceutical Company Limited · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895680

Redox curing-type nonaqueous curable composition

KURARAY NORITAKE DENTAL INC. · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895723

Methods of preparing substituted nucleotide analogs

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895759

Intermediates useful in the preparation of maleimide functionalized polymers

Nektar Therapeutics · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895740

Pyrazolopyrazine kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8895536

Compositions and methods for treating chronic inflammation and inflammatory diseases

Infirst Healthcare Limited · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2804734

GITTERVERLUSTREDUKTION BEI PFLASTERHERSTELLUNG

ACINO AG [DE] · Granted Wed Nov 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Nov 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2912973

BIOMARQUEURS D'EXPRESSION DE GENES ET LEUR UTILISATION POUR DES APPLICATIONS DIAGNOSTIQUES ET PRONOSTIQUES CHEZ DES PATIENTS NECESSITANT EVENTUELLEMENT UN TRAITEMENT FAISANT INTER VENIR UN INHIBITEUR DE HDAC

4SC AG [DE] · Granted Thu Nov 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8901093

Custom vectors for treating and preventing pancreatic cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8901309

Fused triazoles for the treatment or prophylaxis of mild cognitive impairment

Takeda Pharmaceutical Company Limited · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8900880

Viral citrullinated peptides and uses thereof

Toscana Biomarkers S.R.L. · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8901141

Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them

Takeda Pharmaceutical Company Limited · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8900818

Recombinant antigen for diagnosis and prevention of murine typhus

United States of America as represented by the Secretary of the Air Force · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8901113

Methods and compositions for deterring abuse

Acurx Pharmaceuticals, Inc. · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8901095

Selective inhibition of polyglutamine protein expression

The Board of Regents of the University of Texas System · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8900616

System and method for satellite drug delivery

Covidien LP · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8900638

Solid preparation comprising alogliptin and metformin hydrochloride

Takeda Pharmaceutical Company Limited · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8901171

Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent

Takeda Pharmaceutical Company Limited · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8901169

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8900555

Insulin derivative formulations for pulmonary delivery

Nektar Therapeutics · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8900574

Mesenchymal stem cells for the treatment of CNS diseases

BRAINSTORM CELL THERAPEUTICS LTD. · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8900862

Mesh enclosed tissue constructs

The Regents of the University of California · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8901279

Humanized antibodies with anti-tumor activity

TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)